AREG and pulmonary fibrosis: Infected alveolar epithelial cells are thought to be the primary source of these mediators, exacerbating pulmonary inflammation and immune dysfunction [41, 42], and sustained amphiregulin activation may contribute to lung fibrosis and pulmonary symptoms of persistent lung inflammation [43].